In this study, we confirmed that JP1 regulates the mitochondrial metabolic reprogramming of B16F10 and LLC cells through JP1-mediated AMPK/FOXO3a/UQCRC2 signaling, which improves the tumor microenvironment hypoxia. Here, UQCRC2 is linked to neoplasm.